NuCana plc
NCNA Nasdaq· Pharmaceutical Preparations
Last close · Oct 30, 2026
$1.01
KIRA · Stoqly’s AI analyst, in plain words
- NuCana plc lost $38.7M in fiscal 2025.
- Free cash flow was −$9.8M in fiscal 2025. At that burn of $9.8M a year, its $32.7M of cash and short-term investments would last about 3.3 years.
Market cap
$2.3B
P/E
—
Revenue
—
Net income
−$38.7M
Free cash flow
−$9.8M
Operating margin
—
NuCana plc in 30 seconds · fiscal 2025
Does it make a profit?
−$38.7M
No. It lost money last year.
How long would its cash last?
3.3 yrs
Comfortably. It burns $9.8M a year and holds $32.7M, about 3.3 years at that pace.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What NuCana plc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Mar 19, 2026
- Legal name
- NuCana plc
- CIK
- 0001709626
NuCana plc · NCNA · stoqly.net
Results and finances
The last 5 fiscal years. Amounts in USD. Compiled by stoqly.net.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | −$55.8M | −$39.4M | −$34.4M | −$24.3M | −$38.7M |
| Diluted EPS | −$5.37 | −$3.76 | −$3.29 | −$1.66 | $0.00 |
| Cash | |||||
| Cash from operations | −$32.8M | −$28.5M | −$32.9M | −$24.4M | −$9.8M |
| Capital expenditure | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M |
| Free cash flow | −$32.9M | −$28.5M | −$32.9M | −$24.4M | −$9.8M |
| Share count change | 37.4% | 0.4% | 0.6% | 41.1% | 15,038.7% |
| Debt and strength | |||||
| Cash and short-term investments | $81.2M | $50.4M | $21.9M | $8.5M | $32.7M |
| Shareholders' equity | $88.4M | $46.3M | $18.9M | $7.5M | $32.8M |
| Current ratio | 6.1x | 2.8x | 2.0x | 1.4x | 5.6x |
| Interest coverage | — | — | — | — | −1.6x |
| Returns and quality | |||||
| Return on equity | −49.8% | −58.6% | −105.3% | −184.0% | −192.3% |
| Return on tangible equity | −65.5% | −90.8% | −211.8% | −516.0% | −129.7% |
| Altman Z'' | 0.3 | −8.7 | −28.0 | −57.8 | −22.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
NuCana plc · NCNA · stoqly.net
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.01 a share, the company is worth $2.3B.
Compiled and analysed by stoqly.net from SEC EDGAR XBRL filings (CIK 0001709626). Latest version: stoqly.net/companies/ncna. Data updated November 1, 2026. Filed in GBP under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.